Although Cdk4/6 inhibitors have a multitude of effects on cancer cells, one important effect is believed to be the breaking of this feedback loop by preventing phosphorylation of Rb and its dissociation from E2F, such that E2F cannot activate transcription and the cells arrest at the G1/S boundary [117]. The gene discussed is CDK4; the disease is cancer.